Navigation Links
Epilepsy Drug Helps Diabetic Nerve Damage

Over the weekend, researchers from Eastern Virginia Medical School presented their study that shows the anti-epileptic drug topiramate improves diabetic neuropathy, or nerve damage.Topiramate (Topamax) has long been used to treat epilepsy, and recent research shows it can also promote significant weight loss. In a small study of people with type 2 diabetes, the drug showed evidence of improving symptoms and markers of neuropathy.// Neuropathy is damage to the nerves that produces pain, impaired heat and pain perception, and disordered skin blood flow that predisposes a person to skin ulcers. Those ulcers can often be cause for amputation.
Aaron Vinik, M.D., from Eastern Virginia Medical School in Norfolk, presented the results of a study in which he and colleagues gave a daily dose of topiramate (no more than 100 milligrams/day) to 11 participants with neuropathy. At the end of the eight-week study, markers of neuropathy -- dendrite length, intraepidermal nerve fiber density and peroneal nerve amplitude -- all increased in the patients. What that means, explains Dr. Vinik, is that the nerves were healing. Patients also experienced increased sensitivity to touch and a significant reduction in pain.

There are other benefits of the drug for type 2 diabetes patients as well, says Dr. Vinik. His study shows the drug reduced triglycerides, decreased hemoglobin A1C levels (a measure of long-term blood sugar control), lowered LDL or "bad" cholesterol, and lowered total cholesterol. Since about 65 percent of people with diabetes will die of heart disease, these are significant benefits for patients.


'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug May Relieve Chronic Headaches
6. More Complications Seen In Women With Epilepsy
7. Epilepsy Drugs Found To Lead To Bone Loss
8. Another Use For Epilepsy Drugs
9. Epilepsy Patients Could Benefit From Pacemakers
10. Early Surgery For Treatment Of Epilepsy Questioned
11. Epilepsy Drug Valproate and Lamotrigine Linked To Malformed Fetus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research ... Li completed his internship in internal medicine at the Emory University and dermatology ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details What ... areas are going to grow at the fastest rates? ... assessing data, trends, opportunities and prospects. Our 190-page ... most lucrative areas in the industry and the future ... sales across the all the major categories of the ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
Breaking Medicine Technology: